APA

Matthews D. J., Yakes F. M., Chen J., Tadano M., Bornheim L., Clary D. O., Tai A., Wagner J. M., Miller N., Kim Y. D., Robertson S., Murray L. & Karnitz L. M. (20070409). Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo. : Cell cycle (Georgetown, Tex.).

Chicago

Matthews David J, Yakes F Michael, Chen Jason, Tadano Michele, Bornheim Lester, Clary Douglas O, Tai Albert, Wagner Jill M, Miller Nicole, Kim Yong D, Robertson Scott, Murray Louis and Karnitz Larry M. 20070409. Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo. : Cell cycle (Georgetown, Tex.).

Harvard

Matthews D. J., Yakes F. M., Chen J., Tadano M., Bornheim L., Clary D. O., Tai A., Wagner J. M., Miller N., Kim Y. D., Robertson S., Murray L. and Karnitz L. M. (20070409). Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo. : Cell cycle (Georgetown, Tex.).

MLA

Matthews David J, Yakes F Michael, Chen Jason, Tadano Michele, Bornheim Lester, Clary Douglas O, Tai Albert, Wagner Jill M, Miller Nicole, Kim Yong D, Robertson Scott, Murray Louis and Karnitz Larry M. Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo. : Cell cycle (Georgetown, Tex.). 20070409.